WAY-207024
WAY-207024 is an orally active gonadotropin releasing hormone receptor (GnRH-R) antagonist (human GnRH: IC50 of 12 nM, rat GnRH: IC50 of 71 nM) . WAY-207024 inhibits rat LH release with an IC50 of 350 nM. WAY-207024 lowers rat plasma leuteinizing hormone (LH) levels after oral administration[1].
Product Specifications
CAS Number
872002-72-7
UNSPSC
12352005
Target
GnRH Receptor
Related Pathways
GPCR/G Protein
Field of Research
Endocrinology
Smiles
CC(C1=CC=C(C2=NC3=CC=CC(N4CCN(CC5=CC=C6N=CC=NC6=C5)CC4)=C3N2)C=C1)(C)C
Molecular Formula
C30H32N6
Molecular Weight
476.62
References & Citations
[1]Jeffrey C Pelletier, et al. Discovery of 6- ({4-[2- (4-tert-butylphenyl) -1H-benzimidazol-4-yl]piperazin-1-yl}methyl) quinoxaline (WAY-207024) : an orally active antagonist of the gonadotropin releasing hormone receptor (GnRH-R) . J Med Chem. 2009 Apr 9;52 (7) :2148-52.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS9247457-01 0.1 mg
Anti-NaPi2b/SLC34A2 Reference Antibody (Lifastuzumab)
Sign In for Pricing
View Details MBS9247457-02 5x 0.1 mg
Anti-NaPi2b/SLC34A2 Reference Antibody (Lifastuzumab)
Sign In for Pricing
View Details ![Anti-Glutathione Reductase [Clone 2A4-1G9] - 200 μg](https://cdn.genprice.uk/genprice/uk/genprice2.webp)
13902-200μg 200 µg
Anti-Glutathione Reductase [Clone 2A4-1G9] - 200 μg
Sign In for Pricing
View Details 